Back to News
Feb 12, 2026 4:40 PM

Vistagen Therapeutics Earnings Report: Q3 Overview

Vistagen Therapeutics (NASDAQ:VTGN) just disclosed its Q3 earnings on Thursday, February 12, 2026 at 04:20 PM.

Here's a brief overview of the earnings report.

Earnings

Vistagen Therapeutics missed estimated earnings by -15.38%, reporting an EPS of $-0.45 versus an estimate of $-0.39.

Revenue was up $69 thousand from the same period last year.

Past Earnings Performance

The company missed on EPS by ...